创伤性脑损伤后抗凝血酶Ⅲ恢复Morris水迷宫认知表现,改善线索学习与空间学习
该研究将15只CD1雄性小鼠随机分为严重TBI(控制性皮层撞击:速度6 m/s、深度1 mm、直径3 mm)或假开颅组,分别于伤后15分钟和24小时静脉给予AT-III(250 IU/kg)或赋形剂(生理盐水)。伤后6至14天进行Morris水迷宫测试,包括线索学习、空间学习和探针(记忆)试验,组间差异用Kruskal-Wallis检验(p<0.05)。结果显示,CCI-VEH组累积线索学习成绩最差(26.1±2.4秒),CCI-AT-III组改善(20.3±2.1秒,p<0.01);累积非线索空间学习同样以CCI-VEH组最差(23.4±1.8秒),AT-III改善(17.6±1.5秒,p<0.01);探针试验中AT-III未能显著改善记忆能力;假开颅组学习与记忆均优于所有CCI组(p<0.05)。作者认为,AT-III改善TBI后数周的神经认知恢复,尤其与学习改善相关而非记忆功能,药理学支持增强学习可能有助于新技能获得或再学习以改善TBI后结局。
要点
- 严重TBI小鼠伤后15分钟和24小时静脉给予AT-III 250 IU/kg,伤后6-8天累积线索学习时间由CCI-VEH组26.1±2.4秒改善至CCI-AT-III组20.3±2.1秒(p<0.01)。
- 累积非线索空间学习成绩CCI-VEH组23.4±1.8秒,CCI-AT-III组改善至17.6±1.5秒(p<0.01)。
- 探针试验中AT-III未能显著改善记忆能力。
- 假开颅组学习与记忆均优于所有CCI组(p<0.05)。
- 作者认为,药理学支持增强学习可能有助于新技能获得或再学习以改善TBI后结局。
适用人群与场景
- 15只CD1雄性小鼠,随机接受严重TBI(控制性皮层撞击:速度6 m/s、深度1 mm、直径3 mm)或假开颅手术。
处置流程与药物剂量
- 伤后15分钟和24小时静脉给予AT-III 250 IU/kg或赋形剂(生理盐水)。
- 伤后6至14天进行Morris水迷宫测试:线索学习试验(平台可见)、空间学习试验(平台不可见、有空间线索)、探针(记忆)试验(移除平台、有空间线索)。
研究设计与关键结果
- 研究类型:动物实验(小鼠),15只CD1雄性小鼠随机分入严重TBI或假开颅组,分别接受静脉AT-III(250 IU/kg)或赋形剂,伤后15分钟和24小时给药。
- 累积线索学习(伤后6-8天到达平台的总平均时间,秒)以CCI-VEH组最差(26.1±2.4秒),CCI-AT-III组为20.3±2.1秒(p<0.01)。
- 累积非线索空间学习以CCI-VEH组最差(23.4±1.8秒),AT-III改善至17.6±1.5秒(p<0.01)。
- 探针试验中AT-III未能显著改善记忆能力。
- 假开颅组学习与记忆均优于所有CCI组(p<0.05)。
- 组间差异用Kruskal-Wallis检验(p<0.05)。
证据类型、等级与局限
- 证据类型:动物实验(小鼠),原文标注证据等级为治疗/照护管理,level II。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,AT-III改善TBI后数周的神经认知恢复,尤其与学习改善相关而非记忆功能。
- 作者认为,药理学支持增强学习可能有助于新技能获得或再学习以改善TBI后结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Neuroinflammation and cerebral edema development following severe traumatic brain injury (TBI) affect subsequent cognitive recovery. Independent of its anticoagulant effects, antithrombin III (AT-III) has been shown to block neurovascular inflammation after severe TBI, reduce cerebral endothelial-leukocyte interactions, and decrease blood-brain barrier permeability. We hypothesized that AT-III administration after TBI would improve post-TBI cognitive recovery, specifically enhancing learning, and memory.
METHODS: Fifteen CD1 male mice were randomized to undergo severe TBI (controlled cortical impact [CCI]: velocity, 6 m/s; depth, 1 mm; diameter, 3 mm) or sham craniotomy and received either intravenous AT-III (250 IU/kg) or vehicle (VEH/saline) 15 minutes and 24 hours post-TBI. Animals underwent Morris water maze testing from 6 to 14 days postinjury consisting of cued learning trials (platform visible), spatial learning trials (platform invisible, spatial cues present), and probe (memory) trials (platform removed, spatial cues present). Intergroup differences were assessed by the Kruskal-Wallis test (p < 0.05).
RESULTS: Morris water maze testing demonstrated that cumulative cued learning (overall mean time in seconds to reach the platform on days 6-8) was worst in CCI-VEH animals (26.1 ± 2.4 seconds) compared with CCI-AT-III counterparts (20.3 ± 2.1 seconds, p < 0.01). Cumulative noncued spatial learning was also worst in the CCI-VEH group (23.4 ± 1.8 seconds) but improved with AT-III (17.6 ± 1.5 seconds, p < 0.01). In probe trials, AT-III failed to significantly improve memory ability. Animals that underwent sham craniotomy demonstrated preserved learning and memory compared with all CCI counterparts (p < 0.05).
CONCLUSION: Antithrombin III improves neurocognitive recovery weeks after TBI. This improvement is particularly related to improvement in learning but not memory function. Pharmacologic support of enhanced learning may support new skill acquisition or relearning to improve outcomes after TBI.
LEVEL OF EVIDENCE: Therapeutic/care management, level II.
参考来源
- ElSaadani M, Ahmed SM, Jacovides C, et al. Post-traumatic brain injury antithrombin III recovers Morris water maze cognitive performance, improving cued and spatial learning. J Trauma Acute Care Surg. 2021. PMID: 33605694. doi:10.1097/TA.0000000000003112
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。